(1 - 8 von 8
)
COMUNICADO: CytoSorbents anuncia que Fresenius Medical Care iniciará...
www.europapress.es
MONMOUTH JUNCTION, Nueva Jersey, 2 de junio de PRNewswire/ -- CytoSorbents Corporation , un líder en...
CytoSorbents gibt Verkaufsstart von CytoSorb® in Frankreich, Polen...
www.ots.at
... damit Kunden eine durchgehend positive Erfahrung machen", erklärte Herr Christian Schlaeper, Vizepräsident International Marketing bei ...
CytoSorbents kündigt strategische Partnerschaft mit Fresenius Medical...
www.finanznachrichten.de
Hr. Christian Schlaeper, Vizepräsident International Marketing & Medicine, Fresenius Medical Care erklärte: "Wir glauben, dass CytoSorb® das Potenzial hat,
Cytosorbents Inc.
02c390e.netsolhost.com
Mr. Christian Schlaeper, Vice President International Marketing & Medicine, Fresenius Medical Care stated, "We believe CytoSorb® has the ...
Cytosorbents : CytoSorbents Announces Strategic Partnership...
www.marketscreener.com
MONMOUTH JUNCTION, N.J., Dec. 15, CytoSorbents Corporation , a leader in critical care immunotherapy and blood... | October 15,
Healthcare Conference: New Cost-Conscious Business Models - EPFL
memento.epfl.ch
Christian Schlaeper, VP International Marketing & Medicine, Fresenius Medical Care Deutschland GmbH – Francis Moussy, Leader ...
Fresenius to commercialize CytoSorbents' CytoSorb therapy - NS...
www.nsmedicaldevices.com
Fresenius Medical Care vice-president International Marketing & Medicine Christian Schlaeper said: "We believe CytoSorb has the potential to ...
Stockwatch
www.stockwatch.com
No Hype - just the Facts. Your complete source of news and realtime quotes from the TSX, TSX-V, CSE, Montreal, Nasdaq, NYSE, Amex and OTC Markets.
sortiert nach Relevanz / Datum